Teicoplanin or vancomycin in febrile neutropenic children with cancer: A randomized study on cost effectiveness;Teicoplanine ou vancomycine chez l'enfant en granulopenie febrile post chimiotherapie: Une etude randomisee cout efficacite

Medecine et Maladies Infectieuses

Volumn 27, Issue SPEC. ISS. NOV., 1997, Pages 984-988

  Auperin, A ^a   Cappelli, C ^a   Benhamou, E ^a   Pinna, A ^a   Peeters, P ^a   Atlani, C ^a   Hartmann, O ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Cancer; Chemotherapy; Children; Cost effectiveness; Febrile neutropenia; Glycopeptide antibiotic; Randomized trial; Teicoplanin; Vancomycin

Indexed keywords

ACICLOVIR; AMIKACIN; ANTINEOPLASTIC AGENT; CEFTAZIDIME; GRANULOCYTE COLONY STIMULATING FACTOR; IMIPENEM; TEICOPLANIN; VANCOMYCIN;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; FEVER; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEUTROPENIA; RANDOMIZED CONTROLLED TRIAL; SLEEP TIME;

EID: 0031437228     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-077X(97)80202-8     Document Type: Article

References (13)

1. Langley J. Gold R. Sepsis in febrile neutropenic children with cancer Pediatr Infect Dis J 7 1988 34 35
2. Valteau D. Hartmann O. Brugieres L. Vassal G. Benhamou E. Andremont A. Kalifa C. Lemerle J. Streptococcal septicemia following autologous bone marrow transplantation in children treated with high dose chemotherapy Bone Marrow Transplant 7 1991 415 419
3. Shenep J. Hughes W.T. Roberson P.K. Blankenship K.R. Baker D.K. Meyer W.H. Gigliotti F. Sixbey J.W. Santana V.M. Feldman S. Lott L. Vancomycin, ticarcillin and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile neutropenic children with cancer N Engl J Med 319 1988 1053 1058
4. Schaison G. Leverger G. Pappo M. Chiche D. Efficacy of the combination of ceftazidime/vancomycin in the first line treatment of infection in neutropenic children Pathol Biol 38 1990 557 560
5. Brogden R.N. Peters D.H. Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy Drugs 47 1994 823 854
6. Smith S.R. Cheesbrough J. Spearing R. Davies J.M. Randomized prospective study comparing vancomycin with teicoplanin in the treatment of infections associated with Hickman Catheters Antimicrob Agents Chemother 33 1989 1193 1197
7. Van Der Auwera P. Aoun M. Meunier F. Randomized study of vancomycin versus teicoplanin for the treatment of Gram-positive bacterial infections in immunocompromised hosts Antimicrob Agents Chemother 33 1991 451 457
8. Kureishi A. Jewesson P.J. Rubinger M. Cole C.D. Reece D.E. Phillips G.L. Smith J.A. Chow A.W. Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity Antimicrob Agents Chemother 35 1991 2246 2252
9. Rolston K.V.I. Nguyen H. Amos G. Elting L. Fainstein V. Bodey G.P. A randomized double-blind trial of vancomycin versus teicoplanin for the treatment of Gram-positive bacteremia in patients with cancer J Infect Dis 169 1994 350 355
10. Menichetti F. Martino P. Bucaneve G. Gentile G. D'Antonio D. Liso V. Ricci P. Nosari A.M. Buelli M. Carotenuto M. Fasola G. Jacopino P. Montillo M. Barbabietola G. Girmenia C. Del Favero A. the GIMEMA Infection Program Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies Antimicrob Agents Chemother 38 1994 2041 2046
11. Contra T. Martin N. Scaglione C. Madero L. Diaz M.A. A study of teicoplanin and vancomycin in combination therapy for febrile episodes in neutropenic paediatric patients Can J Infect Dis 6 suppl C 1995 309
12. Larson L.N. Cost determination and analysis Bootman J.L. Townsend R.J. McGhan W.F. Principles of pharmacoeconomics 1991 Harvey Whitney Books Company Cincinnati 34 49
13. Kerr J.R. Barr J.G. Smyth E.T.M. O'Hare J. Technique for calculation of the true costs of antibiotic therapy Eur J Clin Microbiol Infect Dis 11 1992 823 827